天海防務(300008.SZ):長城資產累計減持1700萬股
格隆匯7月8日丨天海防務(300008.SZ)公佈,近日,公司收到長城資產出具的《關於完成股份減持的吿知函》,獲悉長城資產在2025年5月22日至2025年6月27日期間,通過集中競價方式合計減持公司股份1,700萬股,佔公司總股本的0.98%。本次減持計劃實施完畢後,長城資產持有的公司股份從106,429,235股減少至89,429,235股,佔公司總股本的比例由6.16%減少至5.18%,權益變動觸及1%的整數倍。長城資產根據其自身實際情況,經綜合考慮決定提前終止本次減持計劃,剩餘未減持股份在本次減持計劃期限內不再減持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.